// App-Quantinova.ai

P39 : Treatment of scleromyxedema with intravenous immunoglobulin

Researchers

Presenter

  • Chung Mun Alice Lin

Principal Investigators

  • Faye A. H Cooles

  • Simon J Meggitt

  • Bridget Griffiths

Medical Centers

  • Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UNITED KINGDOM

  • Rheumatology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UNITED KINGDOM

  • Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UNITED KINGDOM

  • Rheumatology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Hypothyroidism

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Methotrexate

  • Lanthanum carbonate

  • IVIG

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved